287 related articles for article (PubMed ID: 29692578)
1. Vancomycin, linezolid and daptomycin susceptibility pattern among clinical isolates of methicillin-resistant
Husain A; Rawat V; Umesh ; Kumar M; Verma PK
J Lab Physicians; 2018; 10(2):145-148. PubMed ID: 29692578
[TBL] [Abstract][Full Text] [Related]
2. Worrisome trends in rising minimum inhibitory concentration values of antibiotics against methicillin resistant Staphylococcus aureus - Insights from a tertiary care center, South India.
Niveditha N; Sujatha S
Braz J Infect Dis; 2015; 19(6):585-9. PubMed ID: 26361841
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Activity of Vancomycin, Teicoplanin, Linezolid and Daptomycin Against Methicillin-Resistant
Xu Y; Wang B; Zhao H; Wang X; Rao L; Ai W; Yu J; Guo Y; Wu X; Yu F; Chen S
Infect Drug Resist; 2021; 14():5449-5456. PubMed ID: 34949928
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of daptomycin & linezolid against methicillin resistant Staphylococcus aureus & vancomycin resistant enterococci isolated from hospitalized cases in Central India.
Chitnis S; Katara G; Hemvani N; Pareek S; Chitnis DS
Indian J Med Res; 2013 Jan; 137(1):191-6. PubMed ID: 23481072
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activity of ceftaroline tested against staphylococci with reduced susceptibility to linezolid, daptomycin, or vancomycin from U.S. hospitals, 2008 to 2011.
Sader HS; Flamm RK; Jones RN
Antimicrob Agents Chemother; 2013 Jul; 57(7):3178-81. PubMed ID: 23629712
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
Steinkraus G; White R; Friedrich L
J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin, teicoplanin, daptomycin, and linezolid MIC creep in methicillin-resistant Staphylococcus aureus is associated with clonality.
Hsieh YC; Lin YC; Huang YC
Medicine (Baltimore); 2016 Oct; 95(41):e5060. PubMed ID: 27741120
[TBL] [Abstract][Full Text] [Related]
8. Telavancin demonstrates activity against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to vancomycin, daptomycin, and linezolid in broth microdilution MIC and one-compartment pharmacokinetic/pharmacodynamic models.
Smith JR; Barber KE; Hallesy J; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2015 Sep; 59(9):5529-34. PubMed ID: 26124162
[TBL] [Abstract][Full Text] [Related]
9. Glycopeptide and daptomycin susceptibility trends among clinical isolates of methicillin-resistant Staphylococcus aureus in a tertiary care center in North India.
Singh A; Prasad KN; Rai RP; Singh SK; Rahman M; Tripathi A; Srivastava JK
J Infect Public Health; 2015; 8(4):341-5. PubMed ID: 25797814
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of linezolid, tigecycline, and daptomycin on methicillin-resistant Staphylococcus aureus blood isolates from adult patients, 2006-2008: stratified analysis by vancomycin MIC.
Kao TM; Wang JT; Weng CM; Chen YC; Chang SC
J Microbiol Immunol Infect; 2011 Oct; 44(5):346-51. PubMed ID: 21524980
[TBL] [Abstract][Full Text] [Related]
11. An investigation of vancomycin minimum inhibitory concentration creep among methicillin-resistant Staphylococcus aureus strains isolated from pediatric patients and healthy children in Northern Taiwan.
Chang CN; Lo WT; Chan MC; Yu CM; Wang CC
J Microbiol Immunol Infect; 2017 Jun; 50(3):362-369. PubMed ID: 26297168
[TBL] [Abstract][Full Text] [Related]
12. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS
Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
[TBL] [Abstract][Full Text] [Related]
13. [Investigation of antibiotic resistance patterns and reduced vancomycin susceptibilities of methicillin-resistant Staphylococcus aureus isolates: a multi-center study].
Çıkman A; Aydın M; Gülhan B; Parlak M; Gültepe B; Kalaycı Y; Bayındır Bilmen F; Solmaz S; Özekinci T
Mikrobiyol Bul; 2015 Apr; 49(2):240-8. PubMed ID: 26167824
[TBL] [Abstract][Full Text] [Related]
14. Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types.
Farrell DJ; Flamm RK; Sader HS; Jones RN
Int J Antimicrob Agents; 2014 Apr; 43(4):323-7. PubMed ID: 24411474
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of daptomycin and comparator agents against Staphylococcus aureus isolates from intravenous drug users with right endocarditis.
Sanchez-Porto A; Casanova-Roman M; Casas-Ciria J; Santaella MJ; Sanchez-Morenilla I; Eiros-Bouza JM
Infez Med; 2010 Jun; 18(2):108-12. PubMed ID: 20610933
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of methicillin-resistant Staphylococcus aureus isolates from skin and soft tissue infections to vancomycin, daptomycin, linezolid and tedizolid.
Vanegas Múnera JM; Ocampo Ríos AM; Urrego DM; Jiménez Quiceno JN
Braz J Infect Dis; 2017; 21(5):493-499. PubMed ID: 28432878
[TBL] [Abstract][Full Text] [Related]
17. The effect of inoculum size on selection of in vitro resistance to vancomycin, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus.
Rio-Marques L; Hartke A; Bizzini A
Microb Drug Resist; 2014 Dec; 20(6):539-43. PubMed ID: 25010140
[TBL] [Abstract][Full Text] [Related]
18. Linezolid minimum inhibitory concentration (MIC) creep in methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates at a single Japanese center.
Miyazaki M; Nagata N; Miyazaki H; Matsuo K; Takata T; Tanihara S; Kamimura H
Biol Pharm Bull; 2014; 37(4):679-82. PubMed ID: 24694615
[TBL] [Abstract][Full Text] [Related]
19. The Prevalence of Vancomycin-Intermediate Staphylococcus aureus and Heterogeneous VISA Among Methicillin-Resistant Strains Isolated from Pediatric Population in a Turkish University Hospital.
Mirza HC; Sancak B; Gür D
Microb Drug Resist; 2015 Oct; 21(5):537-44. PubMed ID: 25919019
[TBL] [Abstract][Full Text] [Related]
20. A correlation between reduced susceptibilities to vancomycin and daptomycin among the MRSA isolates selected in mutant selection window of both vancomycin and daptomycin.
Fujimura S; Nakano Y; Watanabe A
J Infect Chemother; 2014 Dec; 20(12):752-6. PubMed ID: 25287155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]